Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
about
GFF MDI for the improvement of lung function in COPD - A look at the PINNACLE-1 and PINNACLE-2 data and beyond.A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstrRandomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.New Therapies for Asthma and Chronic Obstructive Pulmonary Disease.A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
P2860
Q36356295-28AD9446-B34D-4C51-B62B-F92EE1D6BE21Q37563982-6700E580-B6D0-45A2-BBFE-64A4D1991B91Q52562726-9F686ABA-B224-4632-B0E2-AC89B70487EAQ53645314-DECB8E0C-6E9A-4AD6-BB15-410088E286E9Q53839703-6215BC81-B2A1-43E3-8A38-5663853A66ADQ55387524-9D99236E-44DB-4C42-8C2D-D6B87B5BBDEEQ58759101-FEA80E89-B785-4E4D-B312-FD947460119A
P2860
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-response to inhaled glyco ...... with moderate-to-severe COPD.
@en
Dose-response to inhaled glyco ...... echnology metered dose inhaler
@nl
type
label
Dose-response to inhaled glyco ...... with moderate-to-severe COPD.
@en
Dose-response to inhaled glyco ...... echnology metered dose inhaler
@nl
prefLabel
Dose-response to inhaled glyco ...... with moderate-to-severe COPD.
@en
Dose-response to inhaled glyco ...... echnology metered dose inhaler
@nl
P2093
P2860
P1433
P1476
Dose-response to inhaled glyco ...... with moderate-to-severe COPD.
@en
P2093
Chad Orevillo
Colin Reisner
Earl St Rose
Edward M Kerwin
Gary T Ferguson
James Pearle
Leonardo M Fabbri
Michael Golden
Patrick Darken
Roberto Rodriguez-Roisin
P2860
P2888
P356
10.1186/S12931-016-0426-4
P577
2016-09-02T00:00:00Z
P6179
1004798603